0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Understanding Mechanisms of Resistance in Metastatic Castration-resistant Prostate Cancer: The Role of the Androgen Receptor.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          After initiation of androgen deprivation therapy (ADT), most patients progress to castration-resistant prostate cancer (CRPC) within 2 or 3 yr. In the USA, approximately 67000 men are estimated to have metastatic CRPC.

          Related collections

          Author and article information

          Journal
          Eur Urol Focus
          European urology focus
          Elsevier BV
          2405-4569
          2405-4569
          Dec 2016
          : 2
          : 5
          Affiliations
          [1 ] Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. Electronic address: d.tilki@uke.de.
          [2 ] Department of Urology, Northwestern Medicine, Chicago, IL, USA.
          [3 ] Department of Urology, School of Medicine, University of California-Davis, Sacramento, CA, USA.
          Article
          S2405-4569(16)30171-7
          10.1016/j.euf.2016.11.013
          28723515
          21976c0e-43eb-40ec-ac6b-d7f0b79f029b
          History

          Androgen receptor,Mechanisms,Metastasis,Review,Castration-resistant prostate cancer

          Comments

          Comment on this article